Amgen Inc. buy Royal Bank of Canada
Start price
24.01.25
/
50%
€262.90
Target price
24.01.26
€308.19
Performance (%)
10.18%
End price
25.01.26
€289.65
Summary
This prediction ended on 25.01.26 with a price of €289.65. The prediction had a final performance of 10.18%. Royal_Bank_of_Canada has a follow-up prediction for Amgen Inc. where he still thinks Amgen Inc. is a Buy. Dividends of €9.41 are taken into consideration when calculating the performance. Royal_Bank_of_Canada has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y |
|---|---|---|---|
| Amgen Inc. | -3.105% | -3.105% | 8.025% |
| iShares Core DAX® | -6,02 % | -4,60 % | 1,27 % |
| iShares Nasdaq 100 | 0,51 % | 0,16 % | 14,57 % |
| iShares Nikkei 225® | -7,16 % | -2,21 % | 28,11 % |
| iShares S&P 500 | -0,26 % | -0,84 % | 10,20 % |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Amgen Inc. diskutieren
Amgen Inc. (NASDAQ: AMGN) had its "outperform" rating re-affirmed by analysts at Royal Bank of Canada. They now have a $324.00 price target on the stock.
Ratings data for AMGN provided by MarketBeat
In the thread Trading Amgen Inc.
Die von Royal_Bank_of_Canada gewählte maximale Laufzeit wurde überschritten